Compare UFG & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | UFG | NMTC |
|---|---|---|
| Founded | 2021 | 2009 |
| Country | Singapore | United States |
| Employees | 26 | N/A |
| Industry | Oil Refining/Marketing | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.6M | 29.2M |
| IPO Year | N/A | 2010 |
| Metric | UFG | NMTC |
|---|---|---|
| Price | $0.72 | $2.43 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $11.90 |
| AVG Volume (30 Days) | ★ 98.4K | 49.3K |
| Earning Date | 04-22-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 80.43 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $9,097,692.00 |
| Revenue This Year | $3.95 | N/A |
| Revenue Next Year | N/A | $31.90 |
| P/E Ratio | $211.08 | ★ N/A |
| Revenue Growth | N/A | ★ 163.47 |
| 52 Week Low | $0.60 | $0.55 |
| 52 Week High | $9.91 | $5.40 |
| Indicator | UFG | NMTC |
|---|---|---|
| Relative Strength Index (RSI) | 45.27 | 27.73 |
| Support Level | $0.64 | $0.67 |
| Resistance Level | $0.88 | $3.41 |
| Average True Range (ATR) | 0.07 | 0.24 |
| MACD | -0.00 | -0.06 |
| Stochastic Oscillator | 29.69 | 0.48 |
Uni-Fuels Holdings Ltd is a service provider of marine fuel solutions. It operates on an integrated business model, serving customers through two operating models: sales of marine fuels solutions and brokerage (i.e., acting as an intermediary between marine fuels suppliers and customers for a commission). The various marine fuel products offered by the company include very low sulfur fuel oil, high sulfur fuel oil, marine gas oil, and bio marine fuel. Its customers are mainly shipping companies and other fuel suppliers operating in market sectors such as bulk, tanker, offshore, container, general cargo, tug and barge, car carrier, cruise, yacht, and dredging. Geographically, the company derives maximum revenue from Singapore, and the rest from Malaysia, Hong Kong, China, and other regions.
NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.